| Source NDC Code |
|
Target HCPCS Code |
00074-1044-01
EMRELIS 20 MG VIAL
|
⇄
|
C9306
Injection, telisotuzumab vedotin-tllv, 1 mg
|
| Detail Information |
| Relationship Start Date |
10/01/2025 |
| Relationship End Date |
12/31/2025 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00074-1044-01
EMRELIS 20 MG VIAL
|
⇄
|
J9326
Injection, telisotuzumab vedotin-tllv, 1 mg
|
| Detail Information |
| Relationship Start Date |
01/01/2026 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00074-1044-01
EMRELIS 20 MG VIAL
|
⇄
|
J9999
Not otherwise classified, antineoplastic drugs
|
| Detail Information |
| Relationship Start Date |
10/01/2025 |
| Relationship End Date |
12/31/2025 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
00074-1044-01
Emrelis
|
⇄
|
J9326
Telisotuzumab vedotin-tllv
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|